171 related articles for article (PubMed ID: 14617206)
1. The role of B cells and alloantibody in the host response to human organ allografts.
Vongwiwatana A; Tasanarong A; Hidalgo LG; Halloran PF
Immunol Rev; 2003 Dec; 196():197-218. PubMed ID: 14617206
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological analyses of transplant glomerulopathy cases.
Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
[TBL] [Abstract][Full Text] [Related]
3. Antibody-mediated rejection: treatment alternatives and outcomes.
Singh N; Pirsch J; Samaniego M
Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
[TBL] [Abstract][Full Text] [Related]
4. Comparing transplant glomerulopathy in the absence of C4d deposition and donor-specific antibodies to chronic antibody-mediated rejection.
Torres IB; Salcedo M; Moreso F; Sellarés J; Castellá E; Azancot MA; Perelló M; Cantarell C; Serón D
Clin Transplant; 2014 Oct; 28(10):1148-54. PubMed ID: 25103874
[TBL] [Abstract][Full Text] [Related]
5. Pathology of C4d-negative antibody-mediated rejection in renal allografts.
Haas M
Curr Opin Organ Transplant; 2013 Jun; 18(3):319-26. PubMed ID: 23283250
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological analysis of transplant glomerulopathy cases.
Shimizu T; Ishida H; Shirakawa H; Omoto K; Tsunoyama K; Iida S; Tanabe K; Yamaguchi Y
Clin Transplant; 2009 Aug; 23 Suppl 20():39-43. PubMed ID: 19594595
[TBL] [Abstract][Full Text] [Related]
7. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
8. Alloantibodies and the outcome of cadaver kidney allografts.
Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
[TBL] [Abstract][Full Text] [Related]
9. C4d-positive interacinar capillaries correlates with donor-specific antibody-mediated rejection in pancreas allografts.
Torrealba JR; Samaniego M; Pascual J; Becker Y; Pirsch J; Sollinger H; Odorico J
Transplantation; 2008 Dec; 86(12):1849-56. PubMed ID: 19104433
[TBL] [Abstract][Full Text] [Related]
10. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
[TBL] [Abstract][Full Text] [Related]
11. Alloimmune-induced intragraft lymphoid neogenesis promotes B-cell tolerance breakdown that accelerates chronic rejection.
Sicard A; Chen CC; Morelon E; Thaunat O
Curr Opin Organ Transplant; 2016 Aug; 21(4):368-74. PubMed ID: 27258579
[TBL] [Abstract][Full Text] [Related]
12. Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates.
Smith RN; Kawai T; Boskovic S; Nadazdin O; Sachs DH; Cosimi AB; Colvin RB
Am J Transplant; 2006 Aug; 6(8):1790-8. PubMed ID: 16780551
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E
World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958
[TBL] [Abstract][Full Text] [Related]
14. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
15. Reviewing the pathogenesis of antibody-mediated rejection and renal graft pathology after kidney transplantation.
Morozumi K; Takeda A; Otsuka Y; Horike K; Gotoh N; Narumi S; Watarai Y; Kobayashi T
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():4-8. PubMed ID: 26971899
[TBL] [Abstract][Full Text] [Related]
16. Renal allograft pathology in the sensitized patient.
Cornell LD
Curr Opin Organ Transplant; 2013 Jun; 18(3):327-36. PubMed ID: 23619513
[TBL] [Abstract][Full Text] [Related]
17. Improving survival during heart transplantation: diagnosis of antibody-mediated rejection and techniques for the prevention of graft injury.
Patel JK; Kobashigawa JA
Future Cardiol; 2012 Jul; 8(4):623-35. PubMed ID: 22871199
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
19. Pathologic features of antibody-mediated rejection in renal allografts: an expanding spectrum.
Haas M
Curr Opin Nephrol Hypertens; 2012 May; 21(3):264-71. PubMed ID: 22388553
[TBL] [Abstract][Full Text] [Related]
20. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody.
Ionescu DN; Girnita AL; Zeevi A; Duquesnoy R; Pilewski J; Johnson B; Studer S; McCurry KR; Yousem SA
Transpl Immunol; 2005 Oct; 15(1):63-8. PubMed ID: 16223674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
